Chronic Lower Back Pain Market 2025

Chronic Lower Back Pain Market Definition

Chronic lower back pain (CLBP) refers to persistent pain in the lower back region that lasts for 12 weeks or longer, often impacting daily activities and quality of life. It is a prevalent condition that affects a broad spectrum of individuals across age groups, though it is most observed in middle-aged and older adults. It is a common condition that can significantly impact quality of life, leading to reduced mobility, emotional distress and difficulty in performing daily activities. The chronic lower back pain market consists of sales, by entities (organizations, sole traders and partnerships) that arise from a variety of underlying causes, including structural, neurological and muscular issues and its management requires tailored approaches depending on the pain type and severity. Chronic low back pain is the major cause of disability and psychological issues such as stress, depression and/or anxiety.

Chronic Lower Back Pain Market Size

The global chronic lower back pain market reached a value of nearly $7,723.22 million in 2024, having grown at a compound annual growth rate (CAGR) of 2.60% since 2019. The market is expected to grow from $7,723.22 million in 2024 to $9,704.02 million in 2029 at a rate of 4.67%. The market is then expected to grow at a CAGR of 4.36% from 2029 and reach $12,015.07 million in 2034. Growth in the historic period resulted from the favorable government initiatives, growing awareness about pain management and strong economic growth in emerging markets. Factors that negatively affected growth in the historic period were low health access in developing countries. Going forward, increasing healthcare expenditure, rising aging population, rising prevalence of chronic diseases and increasing healthcare access in emerging markets will drive the growth. Factor that could hinder the growth of the chronic lower back pain market in the future include limited availability of skilled professionals.

Chronic Lower Back Pain Market Drivers

The key drivers of the chronic lower back pain market include: Increasing Healthcare Expenditure Increasing healthcare expenditures globally are expected to help the growth of the chronic lower back pain market going forward. As governments and private sectors allocate more resources towards healthcare, there is a greater capacity for investment in advanced diagnostics, treatments and patient care for chronic conditions, including lower back pain. This increase in spending facilitates better access to healthcare services, enabling early diagnosis and more effective management of chronic lower back pain. For instance, in January 2024, according to National Health Expenditures Accounts (NHEA) by KFF, a US based independent source for health policy research, polling and journalism, Health spending in the United States is expected to rise by 5% from 2023 to 2024, reaching $4.9 trillion. Coverage for new treatments will vary among payers and health plans. By 2030, out-of-pocket spending on retail prescription drugs is projected to total $48.1 billion. Additionally, according to National Health Expenditures Accounts (NHEA) by KFF, a US-based independent source for health policy research, polling and journalism, health spending in the USA is expected to rise by 5% from 2023 to 2024, reaching $4.9 trillion. Therefore, increasing healthcare expenditure globally is driving the growth of the chronic lower back pain market in the forecast period.

Chronic Lower Back Pain Market Restraints

The key restraints on the chronic lower back pain market include: Limited Availability Of Skilled Professionals The limited availability of skilled professionals is expected to restrict the growth of the chronic lower back pain market. Chronic lower back pain often requires a multidisciplinary approach, involving specialists such as orthopedic surgeons, physiotherapists, pain management experts and chiropractors. A shortage of these professionals can lead to longer wait times for patients, delayed diagnosis and suboptimal treatment outcomes. For instance, in January 2023, according to a study published by the World Health Organization (WHO), there is expected to be an anticipated shortfall of 10 million healthcare workers globally by 2030 from 65 million in 2020, mainly in low- and middle-income nations. Therefore, the limited availability of skilled professionals will restrict the growth of the chronic lower back pain market.

Chronic Lower Back Pain Market Trends

Major trends shaping the chronic lower back pain market include: Innovative Spinal Cord Stimulation Approved For Non-Surgical Back And Leg Pain Major companies operating in the chronic lower back pain market are focusing on innovative spinal cord stimulation approved for non-surgical back and leg pain. These advancements in spinal cord stimulation technology provide effective pain management for patients who either do not respond well to conventional therapies or are not ideal candidates for surgery. For instance, in February 2024, Boston Scientific Corporation, a US-based medical technology company, announced that the U.S. Food and Drug Administration (FDA) has granted an expanded indication for its Wave Writer spinal cord stimulation (SCS) systems, allowing their use for treating chronic low back and leg pain in individuals without prior back surgery, referred to as non-surgical back pain (NSBP). This approval broadens the application of Wave Writer devices, which were previously cleared for managing chronic pain following surgical procedures. The Wave Writer systems work by delivering mild electrical pulses to specific nerves along the spinal cord, effectively blocking pain signals before they reach the brain. AI-Infused Spinal Cord Stimulation Redefines Pain Therapy Companies operating in the chronic lower back pain market are focusing on artificial intelligence (AI)- infused spinal cord stimulation redefines pain therapy. This technology improves the accuracy and efficacy of treatment but also reduces the need for manual adjustments by healthcare providers, leading to better patient outcomes. For instance, in September 2024, Nevro, a US-based medical device company, launched HFX AdaptivAI (High-Frequency Stimulation Adaptive Artificial Intelligence), an innovative spinal cord stimulation technology that incorporates artificial intelligence to enhance pain management for chronic pain sufferers. This technology is positioned as a unique solution within the spinal cord stimulation market, promising improved patient outcomes through adaptive therapy. HFX AdaptivAI delivers personalized pain relief, utilizing AI and leveraging millions of data points and ten years of innovation and patient care.

Opportunities And Recommendations In The Chronic Lower Back Pain Market

Opportunities – The top opportunities in the chronic lower back pain market segmented by type of pain will arise in the diskogenic pain segment, which will gain $676.24 million of global annual sales by 2029. The top opportunities in the chronic lower back pain market segmented by diagnosis will arise in the imaging guidelines segment, which will gain $869.60 million of global annual sales by 2029. The top opportunities in the chronic lower back pain market segmented by end-user will arise in the hospitals segment, which will gain $788.50 million of global annual sales by 2029. The chronic lower back pain market size will gain the most in USA at $625.79 million. Recommendations- To take advantage of the opportunities, The Business Research Company recommends the chronic lower back pain companies to focus on advancing non-surgical pain management solutions, focus on Ai-infused spinal cord stimulation, focus on developing advanced pain management technologies, focus on personalized Ai-powered solutions, focus on expanding advanced treatment facilities, focus on radicular pain to drive growth, expand in emerging markets, continue to focus on developed markets, focus on expanding strategic distribution partnerships, focus on value-based pricing for chronic lower back pain solutions, focus on targeted digital campaigns, focus on partnerships with healthcare providers and focus on targeted strategies for orthopedic clinics.